Today: 7 February 2026
Subscribe
Browse Category

NYSE:SRFM News 4 December 2025 - 22 December 2025

Surf Air Mobility Stock (SRFM) Jumps in Pre-Market on Dec. 22, 2025: Latest News, Forecasts, and What’s Driving the Volatility

Surf Air Mobility Stock (SRFM) Jumps in Pre-Market on Dec. 22, 2025: Latest News, Forecasts, and What’s Driving the Volatility

Surf Air Mobility Inc. (NYSE: SRFM) is starting the week with a noticeable pop. In early trading on Monday, December 22, 2025, SRFM shares were highlighted as a pre-market gainer, rising roughly 10% to around $2.02, according to a Benzinga pre-market movers roundup. Benzinga That move matters because SRFM is a small-cap, high-volatility name—so even modest shifts in sentiment, liquidity, or positioning can translate into sharp percentage swings. Market data trackers also showed SRFM trading above its prior regular-session close in extended hours/pre-market activity (around the $2.08 area in one widely used feed). MarketBeat Below is what’s known as of
22 December 2025
·
Surf Air Mobility (SRFM) Stock Today: Price, Palantir Partnership, Q3 Results and 2026 Forecasts – 4 December 2025

Surf Air Mobility (SRFM) Stock Today: Price, Palantir Partnership, Q3 Results and 2026 Forecasts – 4 December 2025

Surf Air Mobility Inc. (NYSE: SRFM) remains one of the loudest penny stocks in the regional aviation niche — and one of the riskiest. On 4 December 2025, the stock is trading sharply higher intraday while fresh Q3 results, new financing deals and aggressive Wall Street price targets collide with a very real going‑concern warning and heavy dilution risk.Stock Titan+1 Below is a structured look at the latest price action, news, forecasts and analyses as of 4 December 2025. SRFM stock price on 4 December 2025 As of the latest trading data on 4 December 2025, Surf Air Mobility shares
4 December 2025
··

Stock Market Today

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop